[go: up one dir, main page]

DK8591A - INTERLEUKIN-L INHIBITOR - Google Patents

INTERLEUKIN-L INHIBITOR Download PDF

Info

Publication number
DK8591A
DK8591A DK008591A DK8591A DK8591A DK 8591 A DK8591 A DK 8591A DK 008591 A DK008591 A DK 008591A DK 8591 A DK8591 A DK 8591A DK 8591 A DK8591 A DK 8591A
Authority
DK
Denmark
Prior art keywords
interleukin
inhibitor
Prior art date
Application number
DK008591A
Other languages
Danish (da)
Other versions
DK8591D0 (en
DK172763B1 (en
Inventor
Charles H Hannum
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of DK8591A publication Critical patent/DK8591A/en
Publication of DK8591D0 publication Critical patent/DK8591D0/en
Application granted granted Critical
Publication of DK172763B1 publication Critical patent/DK172763B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK199100085A 1988-05-27 1991-01-18 Isolated interleukin-1 (IL-1) inhibitor or precursor polypeptide thereto, isolated DNA molecule encoding it, vector and DK172763B1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US19991588 1988-05-27
US23871388A 1988-08-31 1988-08-31
US23871388 1988-08-31
US26653188A 1988-11-03 1988-11-03
US26653188 1988-11-03
US8902275 1989-05-25
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Publications (3)

Publication Number Publication Date
DK8591A true DK8591A (en) 1991-01-18
DK8591D0 DK8591D0 (en) 1991-01-18
DK172763B1 DK172763B1 (en) 1999-07-05

Family

ID=27394086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100085A DK172763B1 (en) 1988-05-27 1991-01-18 Isolated interleukin-1 (IL-1) inhibitor or precursor polypeptide thereto, isolated DNA molecule encoding it, vector and

Country Status (9)

Country Link
JP (2) JP3192651B2 (en)
KR (1) KR970002917B1 (en)
BR (1) BR8907457A (en)
DK (1) DK172763B1 (en)
FI (2) FI109206B (en)
HU (3) HU222810B1 (en)
NO (2) NO316122B1 (en)
OA (1) OA09631A (en)
WO (1) WO1989011540A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
ATE178094T1 (en) * 1990-05-01 1999-04-15 Chiron Corp INTERLEUKIN-I ANTAGONIST AND ITS USE
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
US5840496A (en) * 1990-10-09 1998-11-24 Chiron Corporation Method for diagnosing endometrial cancer
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
ZA921120B (en) 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
EP3492100B1 (en) 2001-06-26 2021-12-08 Amgen Inc. Antibodies to opgl
JP2005507915A (en) * 2001-10-26 2005-03-24 ノバルティス アクチエンゲゼルシャフト Method for treating osteoarthritis and composition thereof
CA2481074A1 (en) 2002-04-05 2003-10-23 Amgen Inc. Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
MX2007001221A (en) 2004-08-04 2007-03-23 Amgen Inc Antibodies to dkk-1.
EP2592093A1 (en) 2007-08-21 2013-05-15 Amgen, Inc Human c-fms antigen binding proteins
EP2326347A4 (en) * 2008-09-12 2013-03-06 Xbiotech Inc TARGETING PATHOGENIC MONOCYTES
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
MX2013010171A (en) 2011-03-14 2013-11-20 Serodus Asa Antagonists of the interleukin- 1 receptor.
CA2833147A1 (en) 2011-04-15 2012-10-18 Anita SESHIRE Anti- il-1r1 inhibitors for use in cancer
TW201605896A (en) 2013-08-30 2016-02-16 安美基股份有限公司 GITR antigen binding proteins
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
EP3426297A4 (en) 2016-03-08 2019-08-14 Janssen Biotech, Inc. ANTI-GITRANT ANTIBODIES, METHODS AND USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8820676A (en) * 1987-08-26 1989-07-03 Biogen Inc ORGANIC MATERIALS, METHODS FOR PREPARING ORGANIC MATERIALS AND THE USE OF SUCH MATERIALS IN THERAPY.

Also Published As

Publication number Publication date
OA09631A (en) 1993-04-30
KR970002917B1 (en) 1997-03-12
HU9803037D0 (en) 1999-11-29
FI20020545A7 (en) 2002-03-21
HU222810B1 (en) 2003-11-28
DK8591D0 (en) 1991-01-18
HU215434B (en) 1999-04-28
NO316122B1 (en) 2003-12-15
NO905090L (en) 1991-01-28
NO905090D0 (en) 1990-11-23
FI109206B (en) 2002-06-14
FI905812A0 (en) 1990-11-26
JP3192651B2 (en) 2001-07-30
AU3746989A (en) 1989-12-12
AU633831B2 (en) 1993-02-11
BR8907457A (en) 1991-04-02
NO316917B1 (en) 2004-06-21
NO20014783D0 (en) 2001-10-01
JPH03505279A (en) 1991-11-21
HU893412D0 (en) 1991-05-28
WO1989011540A1 (en) 1989-11-30
FI20020545L (en) 2002-03-21
NO20014783L (en) 1991-01-28
DK172763B1 (en) 1999-07-05
JP2001029093A (en) 2001-02-06

Similar Documents

Publication Publication Date Title
FR2632154B1 (en) COMBINE
ATA901789A (en) SOMATOSTATINPEPTID
BR8806093A (en) TREPANO
DK8591A (en) INTERLEUKIN-L INHIBITOR
ATA172889A (en) FURANDERIVATE
ATA900689A (en) CALCITON INPEPTIDE
DK348289D0 (en) RELATIONS
DK381889A (en) benzamide
DE68926597D1 (en) MICROCALCULATOR
BR8902098A (en) ELECTRICIZER
DK113291D0 (en) HOMOGENT ENZYMIMMUNASSAY
BR8906898A (en) JAMELA
DK69489D0 (en) ASPARTATTRANSCARBAMYLASE INHIBITORS
DE68926367D1 (en) Hydroxymethylcyclobutylpurine
DK119691D0 (en) LOEFTESELE
KR890023207U (en) Relationship
DD277186A3 (en) WAELZLAGERSEPARATOR
SE8901229D0 (en) MINOR
KR890018967U (en) wrench
BR8804416A (en) FLYFISH
BR8803070A (en) RENDE-LAPIS
BR8801701A (en) ANTI-IVH
BR8803641A (en) TELE-LOTO
BR6802550U (en) BICYCLE-SKATEBOARD
BR6801430U (en) AUTO-SHADOW

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
AGE Re-establishment of rights: approved
B1 Patent granted (law 1993)
PUP Patent expired